Has Susan Butler, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,081 in general payments to Susan Butler, MD across 85 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Susan Butler, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Susan Butler, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Susan Butler, MD

MOHS-Micrographic Surgery · San Carlos, CANPI 1013118843

Payments from drug & device makers

$2,081in general payments, 2019–2025

Across 85 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$372
Regeneron Healthcare Solutions, Inc.$314
Incyte Corporation$266
Lilly USA, LLC$185
Arcutis Biotherapeutics, Inc.$154
AbbVie$150
plus $641 from 11 others

What the payments were for

Food & beverage$2,06699%
Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen	14	$372
Regeneron Healthcare Solutions, Inc.	12	$314
Incyte Corporation	13	$266
Lilly USA, LLC	9	$185
Arcutis Biotherapeutics, Inc.	6	$154
AbbVie	6	$150
Galderma Laboratories, L.p.	6	$140
Sanofi	4	$131
Organon	4	$112
Johnson & Johnson	2	$62
Novartis	2	$44
Pfizer	2	$34
UCB, Inc.	1	$33
E.r. Squibb & Sons, L.L.C.	1	$28
LEO Pharma Inc.	1	$20
Cipher Pharmaceuticals US LLC	1	$19
Urogen Pharma, Inc.	1	$17

How this compares

$2,081 in reported general payments places this provider in the 45th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California →

Medicare billing

Part B allowed, 2024

$587,835

Medicare patients

386

Services billed

2,210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	21	$1,164
Clindamycin Phosphate	21	$358
Doxycycline Hyclate	19	$171
Cephalexin	30	$169
Mupirocin	24	$131
Desonide	11	$44

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in San Carlos

Michael MortazieOrange$1.2M
Thuzar ShinSacramento$353K
Sarah ArronBurlingame$223K
Christopher Crosbyla Mesa$211K
Abel TorresLoma Linda$136K
Robert ScheinbergOceanside$129K
Sherry RotundaOceanside$99K
Sumaira AasiStanford$66K
Daniel Zelacla Jolla$43K
Ralph MasseySanta Monica$38K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →